SFMBT1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.69160241370037E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.3131000004859E-07 |
Normal-vs-Stage2 |
1.08330000525569E-08 |
Normal-vs-Stage3 |
6.66133814775094E-16 |
Normal-vs-Stage4 |
3.02639999727461E-08 |
Stage1-vs-Stage2 |
5.131700E-02 |
Stage1-vs-Stage3 |
1.63911999999655E-05 |
Stage1-vs-Stage4 |
1.076400E-01 |
Stage2-vs-Stage3 |
1.376760E-01 |
Stage2-vs-Stage4 |
7.087200E-01 |
Stage3-vs-Stage4 |
3.973500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.72929448538639E-11 |
Normal-vs-AfricanAmerican |
6.36909999999213E-05 |
Normal-vs-Asian |
8.918900E-03 |
Caucasian-vs-AfricanAmerican |
7.842200E-01 |
Caucasian-vs-Asian |
9.702800E-01 |
AfricanAmerican-vs-Asian |
8.940000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.3063773113563E-12 |
Normal-vs-Female |
1.01600000002033E-06 |
Male-vs-Female |
2.624000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.86269999927313E-08 |
Normal-vs-Age(41-60Yrs) |
5.08289965672759E-10 |
Normal-vs-Age(61-80Yrs) |
4.54860038523464E-10 |
Normal-vs-Age(81-100Yrs) |
6.207300E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.631790E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.481830E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.120000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.569400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.021200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.182600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.844400E-02 |
Normal-vs-Grade 2 |
1.56960000552431E-09 |
Normal-vs-Grade 3 |
2.56379995011713E-09 |
Normal-vs-Grade 4 |
2.27140528608061E-11 |
Grade 1-vs-Grade 2 |
7.953200E-01 |
Grade 1-vs-Grade 3 |
8.272800E-01 |
Grade 1-vs-Grade 4 |
2.303800E-01 |
Grade 2-vs-Grade 3 |
8.663000E-01 |
Grade 2-vs-Grade 4 |
6.277600E-02 |
Grade 3-vs-Grade 4 |
3.654200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.864800000002E-06 |
Normal-vs-ccB subtype |
1.04779518395048E-11 |
ccA subtype-vs-ccB subtype |
4.103400E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.29349997379791E-09 |
Normal-vs-N1 |
2.040100E-04 |
N0-vs-N1 |
5.422000E-01 |
|
|